Phenomenex Expands Method Development Services

  Phenomenex has announced that PhenoLogix, the company’s in-house analytical services group, has moved to an expanded, stand-alone facility. The 9000-square‑foot laboratory has been designed to develop methods for customers in ultrahigh‑pressure liquid chromatography (UHPLC), LC, LC coupled to mass spectrometry (MS), and gas chromatography (GC), as well as sample preparation, impurity isolations, chiral screening and small‑ to medium‑scale purifications. PhenoLogix provides support for the company’s product line to customers in drug discovery and development, environmental testing, food safety and quality, forensics, and clinical research.   PhenoLogix was cultivated from Phenomenex’s research and development department into a self-contained organization. The new facility features instruments from multiple manufacturers to address a range of applications.    Sean Orlowicz, manager of PhenoLogix, commented: “From method development and transfer to understanding the nuances of current sample preparation techniques, our scientists are dedicated to customer support. We provide our services via phone or on-line communication and even at the customer site if necessary.”    For more information please visit:    www.phenomenex.com